HIV
- Nature or nurture: Factors that influence bnAb development, Cell Host Microbe.
- Structural basis of broad HIV neutralization by a vaccine-induced cow antibody
- Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines.
- A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses
- Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
- Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan.
- Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
- Reprogramming the antigen specificity of B cells using genome-editing technologies.
- The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template
- Antigen-Specific Single B Cell Sorting and Monoclonal Antibody Cloning in Guinea Pigs
- The HIV-1 Envelope Glycoprotein C3/V4 Region Defines a Prevalent Neutralization Epitope Following Immunization
- Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
- Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
- HIV-1 vaccine design through minimizing envelope metastability
- Recent progress in broadly neutralizing antibodies to HIV.
- Targeting the HIV-1 Spike and Coreceptor with Bi- and Trispecific Antibodies for Single-Component Broad Inhibition of Entry
SARS-CoV2
- Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- Broad neutralization of SARS-related viruses by human monoclonal antibodies
- Structural basis of a shared antibody response to SARS-CoV-2
- Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model